China Medicine Corporation
CHME · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $66 | $11 | $35 | $22 |
| - Cash | $0 | $3 | $6 | $0 |
| + Debt | $10 | $0 | $0 | $0 |
| Enterprise Value | $75 | $8 | $29 | $21 |
| Revenue | $65 | $54 | $42 | $24 |
| % Growth | 20.7% | 27.4% | 75.5% | – |
| Gross Profit | $19 | $16 | $12 | $9 |
| % Margin | 29.3% | 29% | 29.4% | 37.4% |
| EBITDA | $13 | $11 | $9 | $6 |
| % Margin | 20.5% | 21.2% | 21.8% | 26.5% |
| Net Income | $2 | $9 | $7 | $5 |
| % Margin | 2.7% | 17% | 16.3% | 20% |
| EPS Diluted | 0.11 | 0.6 | 0.5 | 0.63 |
| % Growth | -81.7% | 20% | -20.6% | – |
| Operating Cash Flow | $17 | $4 | -$2 | -$2 |
| Capital Expenditures | -$4 | -$3 | -$0 | -$1 |
| Free Cash Flow | $13 | $2 | -$3 | -$3 |